62 withdrawn. 62 Phase 2, 18 Phase 1, 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 62 | Withdrawn 62 |
| Phase 1 | 18 | Withdrawn 18 |
| Phase 3 | 6 | Withdrawn 6 |
Follow Arthritis: new trials by email Literature Review of Arthritis trials Research Report on Arthritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cannabichromene Safety in Rheumatoid Arthritis Cannabichromene - Arthritis, Rheumatoid | Phase 1 / Phase 2 | Withdrawn | Crystal Lederhos Smith | 2028-07-15 | 2026-09-23 | |
| Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients Metformin, Val, Cel and Met XR Low, Val, Cel and Met XR High - Type 2 Diabetes, High Blood Pressure | Phase 1 / Phase 2 | Withdrawn | ARKAY Therapeutics | 2026-12-10 | 2026-07-16 | |
| A Study Evaluating the Safety, Tolerability, and Activity of ICM-203 in Subjects With Knee Osteoarthritis. ICM-203 - Osteoarthritis, Knee | Phase 1 / Phase 2 | Withdrawn | ICM Co. Ltd. | 2026-11-15 | 2026-09-08 | |
| Genicular Embolization Using Doxycycline Sclerotherapy Doxycycline Injection - Chronic Knee Pain, Osteoarthritis | Phase 2 | Withdrawn | Campbell Clinic | 2026-06-01 | 2026-02-27 | |
| HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis allogeneic Hope Biosciences adipose-derived mesenchymal stem cells, Normal Saline Solution 0.9% - Juvenile Idiopathic Arthritis (JIA) | Phase 2 | Withdrawn | Hope Biosciences Research Foundation | 2026-01-01 | 2026-01-07 | |
| Genicular Artery Embolization for Reducing Pain in Medically Refractory Symptomatic Knee Osteoarthritis Genicular Artery Embolization, Lipiodol, Simple angiogram - Knee Osteoarthritis, Knee Osteoarthritis (Knee OA) | Phase 2 | Withdrawn | University of Utah | 2025-05-01 | 2026-10-27 | |
| Validate a Pharmacodynamic Model of Oxytocin for Peripheral Analgesic Effects Oxytocin - Osteoarthritis, Knee | Phase 2 | Withdrawn | Wake Forest University Health Sciences | 2025-01-01 | 2024-09-19 | |
| A Pilot Feasibility Study of IM OXT on Fear of Pain and Trust in Physical Therapist During OP Rehabilitation After TKA Oxytocin, Placebo - Osteoarthritis, Knee | Phase 2 | Withdrawn | Wake Forest University Health Sciences | 2024-01-01 | 2021-06-02 | |
| Estimate Serum Oxytocin PD Range in the Periphery Oxytocin - Osteoarthritis, Knee | Phase 2 | Withdrawn | Wake Forest University Health Sciences | 2023-12-01 | 2022-12-30 | |
| Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency abatacept, Placebo - CTLA4 Haploinsufficency, Chronic Cytopenia | Phase 1 / Phase 2 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-11-30 | 2023-12-04 | |
| Platelet-Rich Plasma and the Effects of NSAIDs on Pain and Functional Scores in Knee Osteoarthritis Ibuprofen and PRP, Acetaminophen and PRP, Placebo and PRP - Osteoarthritis of the Knee, Degenerative Osteoarthritis | Phase 1 / Phase 2 | Withdrawn | QC Kinetix LLC | 2023-11-01 | 2024-10-09 | |
| Targeting Senescence to Reduce Osteoarthritis Pain and cartilagE Breakdown (ROPE) High-dose/short-duration Fisetin, Low-dose/sustained-duration Fisetin, Oral placebo capsule - Osteoarthritis, Knee | Phase 1 / Phase 2 | Withdrawn | Austin V Stone | 2023-06-01 | 2022-07-29 | |
| GetHealthy-OA: A Program to Improve Pain and Function for Patients With Knee Osteoarthritis, Obesity, and Depression Fisetin, GetHealthy-OA mind-body program, Placebo oral capsule - Knee Osteoarthritis, Obese | Phase 2 / Phase 3 | Withdrawn | Cale Andrew Jacobs, PhD | 2023-04-01 | 2023-05-01 | |
| A Study of Oxytocin PK After IV Administration in Healthy Subjects and Advanced Knee Arthritis Subjects Oxytocin - Osteoarthritis, Knee | Phase 2 | Withdrawn | Wake Forest University Health Sciences | 2023-01-01 | 2025-08-12 | |
| Investigating RELEARN Neurofeedback as Treatment for Chronic Musculoskeletal Pain RELEARN Neurofeedback, Standard care control - Chronic Knee Pain, Chronic Pain | Phase 2 / Phase 3 | Withdrawn | Redo-Neurosystems | 2022-10-05 | 2024-02-06 | |
| The Use of Cannabinoid Patch for Knee Osteoarthritis Topical CBD Patch, Placebo Patch - Knee Osteoarthritis, CBD | Phase 2 | Withdrawn | Northwell Health | 2022-10-01 | 2023-01-19 | |
| Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-modifying Antirheumatic Drug(s) (bDMARDs) Treatment GS-5718, Placebo to match GS-5718, Tofacitinib 5 mg - Rheumatoid Arthritis | Phase 2 | Withdrawn | Gilead Sciences | 2022-07-01 | 2022-05-18 | |
| Autologous Intra-Articular Micro-Fragmented Adipose Transfer for the Treatment of Thumb Carpometacarpal Joint Arthritis Micro-Fragmented Adipose Tissue (MFAT), Triamcinolone Acetonide 10mg/mL - Arthritis | Phase 2 | Withdrawn | NYU Langone Health | 2022-05-12 | 2024-01-12 | |
| A Study to Test Different Doses of BI 730357 and Find Out Whether They Reduce Symptoms in People With Active Psoriatic Arthritis BI 730357, Placebo - Arthritis, Psoriatic | Phase 2 | Withdrawn | Boehringer Ingelheim | 2022-05-02 | 2021-11-08 | |
| How Does Platelet Dose Impact Clinical Outcomes After PRP Treatment? PRP injection dose (<5 billion platelets), PRP injection dose (between 5 and <10 billion platelets), PRP injection dose (between 10 and <20 billion platelets) - Osteoarthritis, Knee | Phase 2 | Withdrawn | Vanderbilt University Medical Center | 2022-03-06 | 2024-03-26 |
Showing 20 of 62. Sign in to see all of them.
Osteoarthritis (26) · Osteoarthritis, Knee (22) · Arthritis, Rheumatoid (16) · Arthritis, Psoriatic (4) · Arthritis, Juvenile (3) · Joint Diseases (3) · Osteoarthritis, Hip (3) · Sjogren's Syndrome (3) · Diabetes Mellitus, Type 2 (2) · Inflammation (2) · Obesity (2) · Anemia (1) · Axial Spondyloarthritis (1) · Chronic Pain (1)
Musculoskeletal Diseases (61) · Joint Diseases (59) · Rheumatic Diseases (55) · Skin and Connective Tissue Diseases (23) · Autoimmune Diseases (20) · Connective Tissue Diseases (20) · Immune System Diseases (20) · Osteoarthritis (10) · Bone Diseases (8) · Pathological Conditions, Signs and Symptoms (7) · Nutritional and Metabolic Diseases (6) · Spinal Diseases (6) · Spondylarthritis (6) · Spondylitis (6)
Oxytocin (5) · Abatacept (2) · apremilast (2) · Acetaminophen (1) · Adalimumab (1) · Arthroplasty, Replacement, Hip (1) · Botulinum Toxins, Type A (1) · CF101 (1) · Carboxylesterase (1) · Celecoxib (1) · Cholecalciferol (1) · Cilostazol (1) · Denosumab (1) · Dimethyl Fumarate (1) · Doxycycline (1)
Wake Forest University Health Sciences (5) · Translational Biosciences (4) · Indiana University (3) · Sadat City University (2) · ARKAY Therapeutics (1) · AbbVie (1) · Amgen (1) · Atrium Innovations (1) · Austin V Stone (1) · Biogen (1) · Bird Rock Bio, Inc. (1) · Boehringer Ingelheim (1) · Brigham and Women's Hospital (1) · CAPRI Clinic (1) · Cale Andrew Jacobs, PhD (1)
United States (24) · Canada (5) · Panama (4) · Denmark (2) · Egypt (2) · France (2) · Israel (2) · Netherlands (2) · Australia (1) · China (1) · Iran (1) · South Korea (1) · Sweden (1)
James C Eisenach, MD (5) · Jorge Paz-Rodriguez, MD (2) · Alison Heald, MD (1) · Austin Stone, MD, PhD (1) · Bryan M Sakamoto, M.D., PhD (1) · Cale Jacobs, PhD (1) · Chul-Won Ha, M.D. (1) · Crystal L Smith, PhD (1) · Elke Theander, MD. PhD (1) · Erik Imel, MD (1) · Ernesto N Levy, MD (1)
PMID 22150039, PMID 22328739, PMID 22807102, PMID 22885417, PMID 24326779, PMID 24699939, PMID 26881220, PMID 28143470, PMID 34882311
2019 (2), 2009 (1), 2014 (1), R21AR082123 (1)